Quick Takeaways
- This page summarizes Charles L. Pope's Form 4 filing for ORAGENICS INC (OGEN).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 02 Aug 2022, 16:40.
Charles L. Pope - 29 Jul 2022 Form 4 Insider Report for ORAGENICS INC (OGEN)
- Role
- Director
- Signature
- /s/ Mark A. Catchur, as Attorney-in-Fact for Charles L. Pope
- Issuer symbol
- OGEN
- Transactions as of
- 29 Jul 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 02 Aug 2022, 16:40:16 UTC
- Previous filing
- 17 Dec 2021
- Next filing
- 16 Sep 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Charles L. Pope filed Form 4 for ORAGENICS INC (OGEN) on 02 Aug 2022."
What Changed
- Previous filing in this sequence was filed on 17 Dec 2021.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGEN | Non-Employee Director Option (Right to Buy) | Award | $0 | +220,000 | $0.000000 | 220,000 | 29 Jul 2022 | Common Stock | 220,000 | $0.3562 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. |